Kymera Therapeutics Inc (KYMR) Stock offers help to cash-strapped investors
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
Is Kymera Therapeutics Inc (KYMR) Stock a good value investment?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
What does Kymera Therapeutics Inc (KYMR) Stock have to offer?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
Would Kymera Therapeutics Inc (KYMR) Stock like to attract the attention of traders?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
What is happening with Kymera Therapeutics Inc (KYMR) Stock?
Wolfe Research raised the price target for the Kymera Therapeutics Inc (NASDAQ:KYMR) stock to “a Peer perform”. The rating was released on February 15, 2024, according to finviz. The research report from BofA Securities has downgraded the stock from Buy to Neutral, with a price target set at $30. The stock was downgraded by Wells […]
